Product
sintilimab
Name
sintilimab
2 clinical trials
3 abstracts
5 indications
Indication
Biliary Tract CancerIndication
Cervical CancerIndication
Esophageal squamous cell carcinomaIndication
Stomach CancerIndication
NSCLCClinical trial
A Randomized, Open-label, Phase Ib Clinical Study to Evaluate the Efficacy and Safety of IBI110 in Combination With Sintilimab Versus Sintilimab Alone in Neoadjuvant and Adjuvant Therapy of Radically Resectable Non-small Cell Lung CancerStatus: Terminated, Estimated PCD: 2021-12-31
Clinical trial
A Single Arm,Multi-center,Phase Ib/II Clinical Study Evaluating IBI310 Combined With Sintilimab in Patients With Advanced Biliary Tract Cance(BTC)Status: Recruiting, Estimated PCD: 2023-12-31